↓ Skip to main content

Efficient inhibition of EGFR signalling and of tumour growth by antagonistic anti-EGFR Nanobodies

Overview of attention for article published in Cancer Immunology, Immunotherapy, May 2006
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (93rd percentile)
  • High Attention Score compared to outputs of the same age and source (92nd percentile)

Mentioned by

policy
1 policy source
patent
78 patents
wikipedia
1 Wikipedia page

Citations

dimensions_citation
295 Dimensions

Readers on

mendeley
371 Mendeley
citeulike
1 CiteULike
Title
Efficient inhibition of EGFR signalling and of tumour growth by antagonistic anti-EGFR Nanobodies
Published in
Cancer Immunology, Immunotherapy, May 2006
DOI 10.1007/s00262-006-0180-4
Pubmed ID
Authors

Rob C. Roovers, Toon Laeremans, Lieven Huang, Severine De Taeye, Arie J. Verkleij, Hilde Revets, Hans J. de Haard, Paul M. P. van Bergen en Henegouwen

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 371 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Netherlands 3 <1%
Germany 2 <1%
United States 2 <1%
United Kingdom 2 <1%
Belgium 2 <1%
France 1 <1%
Switzerland 1 <1%
Portugal 1 <1%
Saudi Arabia 1 <1%
Other 2 <1%
Unknown 354 95%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 73 20%
Student > Bachelor 64 17%
Student > Master 63 17%
Researcher 62 17%
Student > Doctoral Student 14 4%
Other 30 8%
Unknown 65 18%
Readers by discipline Count As %
Agricultural and Biological Sciences 98 26%
Biochemistry, Genetics and Molecular Biology 90 24%
Medicine and Dentistry 25 7%
Immunology and Microbiology 23 6%
Chemistry 21 6%
Other 36 10%
Unknown 78 21%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 15. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 02 January 2024.
All research outputs
#2,131,412
of 23,924,386 outputs
Outputs from Cancer Immunology, Immunotherapy
#77
of 2,866 outputs
Outputs of similar age
#3,778
of 65,918 outputs
Outputs of similar age from Cancer Immunology, Immunotherapy
#2
of 14 outputs
Altmetric has tracked 23,924,386 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 90th percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 2,866 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.3. This one has done particularly well, scoring higher than 96% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 65,918 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 93% of its contemporaries.
We're also able to compare this research output to 14 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 92% of its contemporaries.